|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:EIF2C2-CHRAC1 (FusionGDB2 ID:25711) |
Fusion Gene Summary for EIF2C2-CHRAC1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: EIF2C2-CHRAC1 | Fusion gene ID: 25711 | Hgene | Tgene | Gene symbol | EIF2C2 | CHRAC1 | Gene ID | 27161 | 54108 |
| Gene name | argonaute RISC catalytic component 2 | chromatin accessibility complex subunit 1 | |
| Synonyms | CASC7|EIF2C2|LINC00980|PPD|Q10 | CHARC1|CHARC15|CHRAC-1|CHRAC-15|CHRAC15|YCL1 | |
| Cytomap | 8q24.3 | 8q24.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein argonaute-2PAZ Piwi domain proteinargonaute 2, RISC catalytic componentcancer susceptibility candidate 7cancer susceptibility candidate 7 (non-protein coding)eukaryotic translation initiation factor 2C, 2long intergenic non-protein coding RN | chromatin accessibility complex protein 1DNA polymerase epsilon subunit p15chromatin accessibility complex 1chromatin accessibility complex 15 kDa proteinhistone-fold protein CHRAC15 | |
| Modification date | 20200327 | 20200313 | |
| UniProtAcc | . | Q9NRG0 | |
| Ensembl transtripts involved in fusion gene | |||